nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CHRM3—muscle of abdomen—Crohn's disease	0.0246	0.211	CbGeAlD
Paroxetine—HTR2A—enteric nervous system—Crohn's disease	0.0231	0.197	CbGeAlD
Paroxetine—HTR2A—myenteric nerve plexus—Crohn's disease	0.0175	0.15	CbGeAlD
Paroxetine—TACR1—smooth muscle tissue—Crohn's disease	0.00688	0.0588	CbGeAlD
Paroxetine—TACR1—digestive system—Crohn's disease	0.00543	0.0465	CbGeAlD
Paroxetine—CHRM5—epithelium—Crohn's disease	0.00525	0.0449	CbGeAlD
Paroxetine—CHRM5—skin of body—Crohn's disease	0.00499	0.0427	CbGeAlD
Paroxetine—TACR1—lymph node—Crohn's disease	0.0031	0.0265	CbGeAlD
Paroxetine—CHRM3—smooth muscle tissue—Crohn's disease	0.00283	0.0242	CbGeAlD
Paroxetine—SLC6A4—digestive system—Crohn's disease	0.0025	0.0214	CbGeAlD
Paroxetine—CHRM3—digestive system—Crohn's disease	0.00223	0.0191	CbGeAlD
Paroxetine—CYP2B6—skin of body—Crohn's disease	0.00203	0.0174	CbGeAlD
Paroxetine—HTR2A—epithelium—Crohn's disease	0.00174	0.0149	CbGeAlD
Paroxetine—HTR2A—smooth muscle tissue—Crohn's disease	0.00168	0.0144	CbGeAlD
Paroxetine—CYP2B6—lymphoid tissue—Crohn's disease	0.00164	0.0141	CbGeAlD
Paroxetine—CYP2B6—digestive system—Crohn's disease	0.00162	0.0139	CbGeAlD
Paroxetine—CYP2C9—digestive system—Crohn's disease	0.00161	0.0138	CbGeAlD
Paroxetine—HTR2A—digestive system—Crohn's disease	0.00132	0.0113	CbGeAlD
Paroxetine—SLC6A2—lymph node—Crohn's disease	0.00126	0.0108	CbGeAlD
Paroxetine—CYP2D6—digestive system—Crohn's disease	0.00121	0.0103	CbGeAlD
Paroxetine—ABCB1—epithelium—Crohn's disease	0.00114	0.00976	CbGeAlD
Paroxetine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00114	0.00169	CcSEcCtD
Paroxetine—Pancytopenia—Mesalazine—Crohn's disease	0.00113	0.00168	CcSEcCtD
Paroxetine—Dysuria—Mesalazine—Crohn's disease	0.00112	0.00165	CcSEcCtD
Paroxetine—Arthropathy—Prednisone—Crohn's disease	0.00111	0.00164	CcSEcCtD
Paroxetine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0011	0.00164	CcSEcCtD
Paroxetine—Pollakiuria—Mesalazine—Crohn's disease	0.0011	0.00163	CcSEcCtD
Paroxetine—Agranulocytosis—Azathioprine—Crohn's disease	0.00109	0.00162	CcSEcCtD
Paroxetine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00109	0.00162	CcSEcCtD
Paroxetine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00109	0.00161	CcSEcCtD
Paroxetine—Weight increased—Mesalazine—Crohn's disease	0.00109	0.00161	CcSEcCtD
Paroxetine—Weight decreased—Mesalazine—Crohn's disease	0.00108	0.0016	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00108	0.0016	CcSEcCtD
Paroxetine—Leukocytosis—Prednisone—Crohn's disease	0.00107	0.00159	CcSEcCtD
Paroxetine—Pneumonia—Mesalazine—Crohn's disease	0.00107	0.00159	CcSEcCtD
Paroxetine—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00106	0.00158	CcSEcCtD
Paroxetine—Ulcer—Prednisone—Crohn's disease	0.00106	0.00158	CcSEcCtD
Paroxetine—Depression—Mesalazine—Crohn's disease	0.00106	0.00157	CcSEcCtD
Paroxetine—Cataract—Prednisone—Crohn's disease	0.00106	0.00157	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00105	0.00156	CcSEcCtD
Paroxetine—Haemoglobin—Azathioprine—Crohn's disease	0.00105	0.00156	CcSEcCtD
Paroxetine—Haemorrhage—Azathioprine—Crohn's disease	0.00105	0.00155	CcSEcCtD
Paroxetine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00104	0.00155	CcSEcCtD
Paroxetine—Jaundice—Mesalazine—Crohn's disease	0.00104	0.00154	CcSEcCtD
Paroxetine—Stomatitis—Mesalazine—Crohn's disease	0.00104	0.00154	CcSEcCtD
Paroxetine—Urinary tract infection—Mesalazine—Crohn's disease	0.00103	0.00153	CcSEcCtD
Paroxetine—Conjunctivitis—Mesalazine—Crohn's disease	0.00103	0.00153	CcSEcCtD
Paroxetine—Sweating—Mesalazine—Crohn's disease	0.00102	0.00151	CcSEcCtD
Paroxetine—Haematuria—Mesalazine—Crohn's disease	0.00101	0.0015	CcSEcCtD
Paroxetine—Hiccups—Prednisone—Crohn's disease	0.00101	0.00149	CcSEcCtD
Paroxetine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00101	0.00149	CcSEcCtD
Paroxetine—Epistaxis—Mesalazine—Crohn's disease	0.001	0.00149	CcSEcCtD
Paroxetine—Sinusitis—Mesalazine—Crohn's disease	0.000998	0.00148	CcSEcCtD
Paroxetine—Agranulocytosis—Mesalazine—Crohn's disease	0.000993	0.00147	CcSEcCtD
Paroxetine—Erythema multiforme—Azathioprine—Crohn's disease	0.000991	0.00147	CcSEcCtD
Paroxetine—ABCB1—mammalian vulva—Crohn's disease	0.00099	0.00847	CbGeAlD
Paroxetine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000988	0.00147	CcSEcCtD
Paroxetine—Haemoglobin—Mesalazine—Crohn's disease	0.00096	0.00142	CcSEcCtD
Paroxetine—Rhinitis—Mesalazine—Crohn's disease	0.000957	0.00142	CcSEcCtD
Paroxetine—Fluid retention—Prednisone—Crohn's disease	0.000955	0.00142	CcSEcCtD
Paroxetine—Haemorrhage—Mesalazine—Crohn's disease	0.000955	0.00142	CcSEcCtD
Paroxetine—Hepatitis—Mesalazine—Crohn's disease	0.000955	0.00142	CcSEcCtD
Paroxetine—Pharyngitis—Mesalazine—Crohn's disease	0.000948	0.00141	CcSEcCtD
Paroxetine—Immune system disorder—Azathioprine—Crohn's disease	0.000947	0.0014	CcSEcCtD
Paroxetine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000945	0.0014	CcSEcCtD
Paroxetine—Neuropathy—Prednisone—Crohn's disease	0.000945	0.0014	CcSEcCtD
Paroxetine—Oedema peripheral—Mesalazine—Crohn's disease	0.000941	0.0014	CcSEcCtD
Paroxetine—Chills—Azathioprine—Crohn's disease	0.000941	0.0014	CcSEcCtD
Paroxetine—Connective tissue disorder—Mesalazine—Crohn's disease	0.000938	0.00139	CcSEcCtD
Paroxetine—Arrhythmia—Azathioprine—Crohn's disease	0.000937	0.00139	CcSEcCtD
Paroxetine—Alopecia—Azathioprine—Crohn's disease	0.000926	0.00137	CcSEcCtD
Paroxetine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000921	0.00137	CcSEcCtD
Paroxetine—Oesophagitis—Prednisone—Crohn's disease	0.000919	0.00136	CcSEcCtD
Paroxetine—Ecchymosis—Prednisone—Crohn's disease	0.00091	0.00135	CcSEcCtD
Paroxetine—Erythema multiforme—Mesalazine—Crohn's disease	0.000903	0.00134	CcSEcCtD
Paroxetine—Pulmonary oedema—Prednisone—Crohn's disease	0.000896	0.00133	CcSEcCtD
Paroxetine—Eye disorder—Mesalazine—Crohn's disease	0.000892	0.00132	CcSEcCtD
Paroxetine—Tinnitus—Mesalazine—Crohn's disease	0.00089	0.00132	CcSEcCtD
Paroxetine—Cardiac disorder—Mesalazine—Crohn's disease	0.000886	0.00131	CcSEcCtD
Paroxetine—ABCB1—lymphoid tissue—Crohn's disease	0.000879	0.00752	CbGeAlD
Paroxetine—Hyperkinesia—Prednisone—Crohn's disease	0.000878	0.0013	CcSEcCtD
Paroxetine—Sepsis—Prednisone—Crohn's disease	0.000873	0.00129	CcSEcCtD
Paroxetine—ABCB1—digestive system—Crohn's disease	0.000868	0.00743	CbGeAlD
Paroxetine—Angiopathy—Mesalazine—Crohn's disease	0.000866	0.00128	CcSEcCtD
Paroxetine—Euphoric mood—Prednisone—Crohn's disease	0.000865	0.00128	CcSEcCtD
Paroxetine—Immune system disorder—Mesalazine—Crohn's disease	0.000863	0.00128	CcSEcCtD
Paroxetine—Mediastinal disorder—Mesalazine—Crohn's disease	0.000861	0.00128	CcSEcCtD
Paroxetine—Chills—Mesalazine—Crohn's disease	0.000857	0.00127	CcSEcCtD
Paroxetine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000855	0.00127	CcSEcCtD
Paroxetine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000847	0.00126	CcSEcCtD
Paroxetine—Alopecia—Mesalazine—Crohn's disease	0.000844	0.00125	CcSEcCtD
Paroxetine—Thrombophlebitis—Prednisone—Crohn's disease	0.000844	0.00125	CcSEcCtD
Paroxetine—Anaemia—Azathioprine—Crohn's disease	0.000844	0.00125	CcSEcCtD
Paroxetine—Diabetes mellitus—Prednisone—Crohn's disease	0.00084	0.00125	CcSEcCtD
Paroxetine—Mental disorder—Mesalazine—Crohn's disease	0.000837	0.00124	CcSEcCtD
Paroxetine—Erythema—Mesalazine—Crohn's disease	0.000831	0.00123	CcSEcCtD
Paroxetine—Malaise—Azathioprine—Crohn's disease	0.000823	0.00122	CcSEcCtD
Paroxetine—Flatulence—Mesalazine—Crohn's disease	0.000819	0.00121	CcSEcCtD
Paroxetine—Leukopenia—Azathioprine—Crohn's disease	0.000817	0.00121	CcSEcCtD
Paroxetine—Vascular purpura—Prednisone—Crohn's disease	0.000816	0.00121	CcSEcCtD
Paroxetine—Tension—Mesalazine—Crohn's disease	0.000816	0.00121	CcSEcCtD
Paroxetine—Dysgeusia—Mesalazine—Crohn's disease	0.000814	0.00121	CcSEcCtD
Paroxetine—Nervousness—Mesalazine—Crohn's disease	0.000807	0.0012	CcSEcCtD
Paroxetine—Cardiac failure congestive—Prednisone—Crohn's disease	0.000805	0.00119	CcSEcCtD
Paroxetine—Back pain—Mesalazine—Crohn's disease	0.000804	0.00119	CcSEcCtD
Paroxetine—Muscle spasms—Mesalazine—Crohn's disease	0.000799	0.00119	CcSEcCtD
Paroxetine—Vomiting—Mercaptopurine—Crohn's disease	0.000795	0.00118	CcSEcCtD
Paroxetine—Injury—Prednisone—Crohn's disease	0.000795	0.00118	CcSEcCtD
Paroxetine—Rash—Mercaptopurine—Crohn's disease	0.000788	0.00117	CcSEcCtD
Paroxetine—Dermatitis—Mercaptopurine—Crohn's disease	0.000788	0.00117	CcSEcCtD
Paroxetine—Vision blurred—Mesalazine—Crohn's disease	0.000783	0.00116	CcSEcCtD
Paroxetine—Tremor—Mesalazine—Crohn's disease	0.000779	0.00116	CcSEcCtD
Paroxetine—Increased appetite—Prednisone—Crohn's disease	0.000777	0.00115	CcSEcCtD
Paroxetine—Amnesia—Prednisone—Crohn's disease	0.000777	0.00115	CcSEcCtD
Paroxetine—Arthralgia—Azathioprine—Crohn's disease	0.000777	0.00115	CcSEcCtD
Paroxetine—Myalgia—Azathioprine—Crohn's disease	0.000777	0.00115	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000772	0.00114	CcSEcCtD
Paroxetine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000771	0.00114	CcSEcCtD
Paroxetine—Anaemia—Mesalazine—Crohn's disease	0.000768	0.00114	CcSEcCtD
Paroxetine—Discomfort—Azathioprine—Crohn's disease	0.000768	0.00114	CcSEcCtD
Paroxetine—Angioedema—Mesalazine—Crohn's disease	0.00076	0.00113	CcSEcCtD
Paroxetine—Purpura—Prednisone—Crohn's disease	0.000758	0.00112	CcSEcCtD
Paroxetine—Malaise—Mesalazine—Crohn's disease	0.00075	0.00111	CcSEcCtD
Paroxetine—Vertigo—Mesalazine—Crohn's disease	0.000747	0.00111	CcSEcCtD
Paroxetine—Syncope—Mesalazine—Crohn's disease	0.000746	0.00111	CcSEcCtD
Paroxetine—Lethargy—Prednisone—Crohn's disease	0.000745	0.00111	CcSEcCtD
Paroxetine—Leukopenia—Mesalazine—Crohn's disease	0.000744	0.0011	CcSEcCtD
Paroxetine—Nausea—Mercaptopurine—Crohn's disease	0.000743	0.0011	CcSEcCtD
Paroxetine—Infection—Azathioprine—Crohn's disease	0.00074	0.0011	CcSEcCtD
Paroxetine—Palpitations—Mesalazine—Crohn's disease	0.000735	0.00109	CcSEcCtD
Paroxetine—Loss of consciousness—Mesalazine—Crohn's disease	0.000731	0.00108	CcSEcCtD
Paroxetine—Osteoarthritis—Prednisone—Crohn's disease	0.00073	0.00108	CcSEcCtD
Paroxetine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00073	0.00108	CcSEcCtD
Paroxetine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000729	0.00108	CcSEcCtD
Paroxetine—Cough—Mesalazine—Crohn's disease	0.000725	0.00108	CcSEcCtD
Paroxetine—Skin disorder—Azathioprine—Crohn's disease	0.000724	0.00107	CcSEcCtD
Paroxetine—Affect lability—Prednisone—Crohn's disease	0.000719	0.00107	CcSEcCtD
Paroxetine—Hypertension—Mesalazine—Crohn's disease	0.000718	0.00106	CcSEcCtD
Paroxetine—Psychotic disorder—Prednisone—Crohn's disease	0.000713	0.00106	CcSEcCtD
Paroxetine—Chest pain—Mesalazine—Crohn's disease	0.000708	0.00105	CcSEcCtD
Paroxetine—Myalgia—Mesalazine—Crohn's disease	0.000708	0.00105	CcSEcCtD
Paroxetine—Arthralgia—Mesalazine—Crohn's disease	0.000708	0.00105	CcSEcCtD
Paroxetine—Anxiety—Mesalazine—Crohn's disease	0.000705	0.00105	CcSEcCtD
Paroxetine—Face oedema—Prednisone—Crohn's disease	0.000705	0.00105	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000703	0.00104	CcSEcCtD
Paroxetine—Discomfort—Mesalazine—Crohn's disease	0.000699	0.00104	CcSEcCtD
Paroxetine—Hypotension—Azathioprine—Crohn's disease	0.000696	0.00103	CcSEcCtD
Paroxetine—Dry mouth—Mesalazine—Crohn's disease	0.000692	0.00103	CcSEcCtD
Paroxetine—Mood swings—Prednisone—Crohn's disease	0.000692	0.00103	CcSEcCtD
Paroxetine—Confusional state—Mesalazine—Crohn's disease	0.000684	0.00101	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000679	0.00101	CcSEcCtD
Paroxetine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000678	0.00101	CcSEcCtD
Paroxetine—Oedema—Mesalazine—Crohn's disease	0.000678	0.00101	CcSEcCtD
Paroxetine—Infection—Mesalazine—Crohn's disease	0.000674	0.001	CcSEcCtD
Paroxetine—Dry skin—Prednisone—Crohn's disease	0.000669	0.000993	CcSEcCtD
Paroxetine—Shock—Mesalazine—Crohn's disease	0.000668	0.00099	CcSEcCtD
Paroxetine—Nervous system disorder—Mesalazine—Crohn's disease	0.000665	0.000987	CcSEcCtD
Paroxetine—Hypokalaemia—Prednisone—Crohn's disease	0.000665	0.000986	CcSEcCtD
Paroxetine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000664	0.000985	CcSEcCtD
Paroxetine—Tachycardia—Mesalazine—Crohn's disease	0.000662	0.000982	CcSEcCtD
Paroxetine—Skin disorder—Mesalazine—Crohn's disease	0.000659	0.000977	CcSEcCtD
Paroxetine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000656	0.000973	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000644	0.000955	CcSEcCtD
Paroxetine—Muscular weakness—Prednisone—Crohn's disease	0.000644	0.000955	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000643	0.000954	CcSEcCtD
Paroxetine—Hypotension—Mesalazine—Crohn's disease	0.000634	0.00094	CcSEcCtD
Paroxetine—Pancreatitis—Prednisone—Crohn's disease	0.000619	0.000918	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000618	0.000917	CcSEcCtD
Paroxetine—Sweating increased—Prednisone—Crohn's disease	0.000615	0.000912	CcSEcCtD
Paroxetine—Feeling abnormal—Azathioprine—Crohn's disease	0.000614	0.00091	CcSEcCtD
Paroxetine—Insomnia—Mesalazine—Crohn's disease	0.000614	0.00091	CcSEcCtD
Paroxetine—Paraesthesia—Mesalazine—Crohn's disease	0.000609	0.000903	CcSEcCtD
Paroxetine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000609	0.000903	CcSEcCtD
Paroxetine—Dyspnoea—Mesalazine—Crohn's disease	0.000605	0.000897	CcSEcCtD
Paroxetine—Somnolence—Mesalazine—Crohn's disease	0.000603	0.000894	CcSEcCtD
Paroxetine—Dyspepsia—Mesalazine—Crohn's disease	0.000597	0.000886	CcSEcCtD
Paroxetine—Decreased appetite—Mesalazine—Crohn's disease	0.00059	0.000875	CcSEcCtD
Paroxetine—Abdominal pain—Azathioprine—Crohn's disease	0.000589	0.000873	CcSEcCtD
Paroxetine—Body temperature increased—Azathioprine—Crohn's disease	0.000589	0.000873	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000586	0.000869	CcSEcCtD
Paroxetine—Fatigue—Mesalazine—Crohn's disease	0.000585	0.000867	CcSEcCtD
Paroxetine—Erectile dysfunction—Prednisone—Crohn's disease	0.000581	0.000862	CcSEcCtD
Paroxetine—Pain—Mesalazine—Crohn's disease	0.00058	0.00086	CcSEcCtD
Paroxetine—Constipation—Mesalazine—Crohn's disease	0.00058	0.00086	CcSEcCtD
Paroxetine—Weight increased—Prednisone—Crohn's disease	0.000575	0.000852	CcSEcCtD
Paroxetine—Weight decreased—Prednisone—Crohn's disease	0.000571	0.000847	CcSEcCtD
Paroxetine—Hyperglycaemia—Prednisone—Crohn's disease	0.000569	0.000844	CcSEcCtD
Paroxetine—Depression—Prednisone—Crohn's disease	0.000561	0.000832	CcSEcCtD
Paroxetine—Feeling abnormal—Mesalazine—Crohn's disease	0.000559	0.000829	CcSEcCtD
Paroxetine—Acute coronary syndrome—Prednisone—Crohn's disease	0.000555	0.000823	CcSEcCtD
Paroxetine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000555	0.000823	CcSEcCtD
Paroxetine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000552	0.000818	CcSEcCtD
Paroxetine—Myocardial infarction—Prednisone—Crohn's disease	0.000552	0.000818	CcSEcCtD
Paroxetine—Hypersensitivity—Azathioprine—Crohn's disease	0.000549	0.000814	CcSEcCtD
Paroxetine—Urticaria—Mesalazine—Crohn's disease	0.000539	0.000799	CcSEcCtD
Paroxetine—Abdominal pain—Mesalazine—Crohn's disease	0.000536	0.000795	CcSEcCtD
Paroxetine—Body temperature increased—Mesalazine—Crohn's disease	0.000536	0.000795	CcSEcCtD
Paroxetine—Bradycardia—Prednisone—Crohn's disease	0.000514	0.000763	CcSEcCtD
Paroxetine—Diarrhoea—Azathioprine—Crohn's disease	0.00051	0.000756	CcSEcCtD
Paroxetine—Haemoglobin—Prednisone—Crohn's disease	0.000508	0.000753	CcSEcCtD
Paroxetine—Haemorrhage—Prednisone—Crohn's disease	0.000505	0.000749	CcSEcCtD
Paroxetine—Hallucination—Prednisone—Crohn's disease	0.000503	0.000746	CcSEcCtD
Paroxetine—Hypersensitivity—Mesalazine—Crohn's disease	0.0005	0.000741	CcSEcCtD
Paroxetine—Connective tissue disorder—Prednisone—Crohn's disease	0.000497	0.000736	CcSEcCtD
Paroxetine—ABCB1—lymph node—Crohn's disease	0.000496	0.00424	CbGeAlD
Paroxetine—Dizziness—Azathioprine—Crohn's disease	0.000493	0.00073	CcSEcCtD
Paroxetine—Asthenia—Mesalazine—Crohn's disease	0.000487	0.000722	CcSEcCtD
Paroxetine—Pruritus—Mesalazine—Crohn's disease	0.00048	0.000712	CcSEcCtD
Paroxetine—Vomiting—Azathioprine—Crohn's disease	0.000474	0.000702	CcSEcCtD
Paroxetine—Eye disorder—Prednisone—Crohn's disease	0.000472	0.0007	CcSEcCtD
Paroxetine—Rash—Azathioprine—Crohn's disease	0.00047	0.000696	CcSEcCtD
Paroxetine—Dermatitis—Azathioprine—Crohn's disease	0.000469	0.000696	CcSEcCtD
Paroxetine—Flushing—Prednisone—Crohn's disease	0.000469	0.000695	CcSEcCtD
Paroxetine—Headache—Azathioprine—Crohn's disease	0.000467	0.000692	CcSEcCtD
Paroxetine—Diarrhoea—Mesalazine—Crohn's disease	0.000464	0.000688	CcSEcCtD
Paroxetine—Angiopathy—Prednisone—Crohn's disease	0.000458	0.00068	CcSEcCtD
Paroxetine—Immune system disorder—Prednisone—Crohn's disease	0.000456	0.000677	CcSEcCtD
Paroxetine—Arrhythmia—Prednisone—Crohn's disease	0.000451	0.000669	CcSEcCtD
Paroxetine—Dizziness—Mesalazine—Crohn's disease	0.000449	0.000665	CcSEcCtD
Paroxetine—Alopecia—Prednisone—Crohn's disease	0.000446	0.000662	CcSEcCtD
Paroxetine—Mental disorder—Prednisone—Crohn's disease	0.000443	0.000656	CcSEcCtD
Paroxetine—Nausea—Azathioprine—Crohn's disease	0.000442	0.000656	CcSEcCtD
Paroxetine—Malnutrition—Prednisone—Crohn's disease	0.00044	0.000652	CcSEcCtD
Paroxetine—Erythema—Prednisone—Crohn's disease	0.00044	0.000652	CcSEcCtD
Paroxetine—Vomiting—Mesalazine—Crohn's disease	0.000431	0.00064	CcSEcCtD
Paroxetine—Rash—Mesalazine—Crohn's disease	0.000428	0.000634	CcSEcCtD
Paroxetine—Dermatitis—Mesalazine—Crohn's disease	0.000427	0.000634	CcSEcCtD
Paroxetine—Headache—Mesalazine—Crohn's disease	0.000425	0.00063	CcSEcCtD
Paroxetine—Vision blurred—Prednisone—Crohn's disease	0.000415	0.000615	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—Crohn's disease	0.000408	0.000605	CcSEcCtD
Paroxetine—Anaemia—Prednisone—Crohn's disease	0.000407	0.000603	CcSEcCtD
Paroxetine—Agitation—Prednisone—Crohn's disease	0.000404	0.000599	CcSEcCtD
Paroxetine—Nausea—Mesalazine—Crohn's disease	0.000403	0.000598	CcSEcCtD
Paroxetine—Angioedema—Prednisone—Crohn's disease	0.000402	0.000596	CcSEcCtD
Paroxetine—Malaise—Prednisone—Crohn's disease	0.000397	0.000588	CcSEcCtD
Paroxetine—Vertigo—Prednisone—Crohn's disease	0.000395	0.000586	CcSEcCtD
Paroxetine—Syncope—Prednisone—Crohn's disease	0.000394	0.000585	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—Crohn's disease	0.000387	0.000573	CcSEcCtD
Paroxetine—Convulsion—Prednisone—Crohn's disease	0.000381	0.000565	CcSEcCtD
Paroxetine—Hypertension—Prednisone—Crohn's disease	0.00038	0.000563	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—Crohn's disease	0.000374	0.000555	CcSEcCtD
Paroxetine—Myalgia—Prednisone—Crohn's disease	0.000374	0.000555	CcSEcCtD
Paroxetine—Anxiety—Prednisone—Crohn's disease	0.000373	0.000553	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000372	0.000552	CcSEcCtD
Paroxetine—Discomfort—Prednisone—Crohn's disease	0.00037	0.000549	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—Crohn's disease	0.000359	0.000532	CcSEcCtD
Paroxetine—Oedema—Prednisone—Crohn's disease	0.000359	0.000532	CcSEcCtD
Paroxetine—Infection—Prednisone—Crohn's disease	0.000357	0.000529	CcSEcCtD
Paroxetine—Shock—Prednisone—Crohn's disease	0.000353	0.000524	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—Crohn's disease	0.000352	0.000522	CcSEcCtD
Paroxetine—Tachycardia—Prednisone—Crohn's disease	0.00035	0.00052	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—Crohn's disease	0.000349	0.000517	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—Crohn's disease	0.000347	0.000515	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000327	0.000485	CcSEcCtD
Paroxetine—Insomnia—Prednisone—Crohn's disease	0.000325	0.000481	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—Crohn's disease	0.000322	0.000478	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—Crohn's disease	0.000316	0.000469	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—Crohn's disease	0.000312	0.000463	CcSEcCtD
Paroxetine—Fatigue—Prednisone—Crohn's disease	0.000309	0.000459	CcSEcCtD
Paroxetine—Constipation—Prednisone—Crohn's disease	0.000307	0.000455	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisone—Crohn's disease	0.000296	0.000439	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000294	0.000435	CcSEcCtD
Paroxetine—Urticaria—Prednisone—Crohn's disease	0.000285	0.000423	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—Crohn's disease	0.000284	0.000421	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—Crohn's disease	0.000284	0.000421	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—Crohn's disease	0.000264	0.000392	CcSEcCtD
Paroxetine—Asthenia—Prednisone—Crohn's disease	0.000258	0.000382	CcSEcCtD
Paroxetine—Pruritus—Prednisone—Crohn's disease	0.000254	0.000377	CcSEcCtD
Paroxetine—Diarrhoea—Prednisone—Crohn's disease	0.000246	0.000364	CcSEcCtD
Paroxetine—Dizziness—Prednisone—Crohn's disease	0.000237	0.000352	CcSEcCtD
Paroxetine—Vomiting—Prednisone—Crohn's disease	0.000228	0.000338	CcSEcCtD
Paroxetine—Rash—Prednisone—Crohn's disease	0.000226	0.000336	CcSEcCtD
Paroxetine—Dermatitis—Prednisone—Crohn's disease	0.000226	0.000335	CcSEcCtD
Paroxetine—Headache—Prednisone—Crohn's disease	0.000225	0.000334	CcSEcCtD
Paroxetine—Nausea—Prednisone—Crohn's disease	0.000213	0.000316	CcSEcCtD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000103	0.000494	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CCR6—Crohn's disease	0.000103	0.000493	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL2RA—Crohn's disease	0.000103	0.000492	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000102	0.00049	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.000102	0.000489	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000101	0.000485	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000101	0.000484	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SEL1L—Crohn's disease	0.0001	0.000481	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	9.98e-05	0.000478	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—PTGER4—Crohn's disease	9.98e-05	0.000478	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	9.95e-05	0.000477	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	9.93e-05	0.000476	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	9.9e-05	0.000474	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	9.86e-05	0.000472	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	9.8e-05	0.000469	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—CXCL8—Crohn's disease	9.54e-05	0.000457	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—FADS1—Crohn's disease	9.52e-05	0.000456	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR9—Crohn's disease	9.18e-05	0.00044	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	9.13e-05	0.000437	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR9—Crohn's disease	9.13e-05	0.000437	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	9.11e-05	0.000437	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR9—Crohn's disease	9.1e-05	0.000436	CbGpPWpGaD
Paroxetine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.1e-05	0.000436	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	9.06e-05	0.000434	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	9.02e-05	0.000432	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR9—Crohn's disease	9.01e-05	0.000432	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	8.99e-05	0.00043	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCR6—Crohn's disease	8.97e-05	0.00043	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GPX4—Crohn's disease	8.91e-05	0.000427	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	8.9e-05	0.000426	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MTMR3—Crohn's disease	8.9e-05	0.000426	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—IL2RA—Crohn's disease	8.78e-05	0.000421	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GCKR—Crohn's disease	8.61e-05	0.000412	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCR6—Crohn's disease	8.59e-05	0.000412	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	8.59e-05	0.000411	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GPR65—Crohn's disease	8.54e-05	0.000409	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	8.51e-05	0.000408	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	8.5e-05	0.000407	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GPR65—Crohn's disease	8.49e-05	0.000407	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.49e-05	0.000407	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GPR65—Crohn's disease	8.46e-05	0.000405	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	8.46e-05	0.000405	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.44e-05	0.000404	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	8.43e-05	0.000404	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	8.43e-05	0.000404	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.42e-05	0.000403	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	8.41e-05	0.000403	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GPR65—Crohn's disease	8.38e-05	0.000401	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	8.35e-05	0.0004	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.34e-05	0.000399	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	8.32e-05	0.000399	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	8.22e-05	0.000394	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—FADS1—Crohn's disease	8.19e-05	0.000392	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	8.18e-05	0.000392	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	8.18e-05	0.000392	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	8.17e-05	0.000391	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	8.15e-05	0.00039	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—RBX1—Crohn's disease	8.11e-05	0.000389	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	8.07e-05	0.000387	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL2RA—Crohn's disease	7.98e-05	0.000382	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PTGER4—Crohn's disease	7.9e-05	0.000378	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—RBX1—Crohn's disease	7.77e-05	0.000372	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MTMR3—Crohn's disease	7.75e-05	0.000371	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL3—Crohn's disease	7.72e-05	0.00037	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL3—Crohn's disease	7.68e-05	0.000368	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GPX4—Crohn's disease	7.67e-05	0.000367	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL3—Crohn's disease	7.65e-05	0.000367	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	7.64e-05	0.000366	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL3—Crohn's disease	7.58e-05	0.000363	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	7.56e-05	0.000362	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	7.47e-05	0.000358	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—ALB—Crohn's disease	7.46e-05	0.000358	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	7.43e-05	0.000356	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	7.4e-05	0.000355	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GCKR—Crohn's disease	7.4e-05	0.000355	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	7.33e-05	0.000351	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MTMR3—Crohn's disease	7.3e-05	0.00035	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MTMR3—Crohn's disease	7.24e-05	0.000347	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TYK2—Crohn's disease	7.23e-05	0.000346	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—UBE2D1—Crohn's disease	7.11e-05	0.000341	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—FADS1—Crohn's disease	6.93e-05	0.000332	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—RIPK2—Crohn's disease	6.9e-05	0.00033	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—JAK2—Crohn's disease	6.9e-05	0.00033	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	6.81e-05	0.000326	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	6.76e-05	0.000324	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL3—Crohn's disease	6.73e-05	0.000322	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	6.61e-05	0.000316	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—RASGRP1—Crohn's disease	6.51e-05	0.000312	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GPX4—Crohn's disease	6.49e-05	0.000311	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	6.46e-05	0.00031	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL3—Crohn's disease	6.44e-05	0.000309	CbGpPWpGaD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.44e-05	0.000308	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	6.43e-05	0.000308	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	6.41e-05	0.000307	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.41e-05	0.000307	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.38e-05	0.000306	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	6.35e-05	0.000304	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CXCL8—Crohn's disease	6.3e-05	0.000302	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GCKR—Crohn's disease	6.27e-05	0.0003	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	6.23e-05	0.000298	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR6—Crohn's disease	6.08e-05	0.000291	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR6—Crohn's disease	6.05e-05	0.00029	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—FADS1—Crohn's disease	6.04e-05	0.000289	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR6—Crohn's disease	6.03e-05	0.000289	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—IL6—Crohn's disease	5.99e-05	0.000287	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR6—Crohn's disease	5.97e-05	0.000286	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	5.96e-05	0.000285	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	5.92e-05	0.000284	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—JAK2—Crohn's disease	5.9e-05	0.000283	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	5.9e-05	0.000283	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SOCS1—Crohn's disease	5.89e-05	0.000282	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	5.85e-05	0.00028	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—FADS1—Crohn's disease	5.69e-05	0.000273	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	5.65e-05	0.000271	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GPX4—Crohn's disease	5.65e-05	0.000271	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	5.65e-05	0.00027	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—FADS1—Crohn's disease	5.64e-05	0.00027	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	5.62e-05	0.000269	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.52e-05	0.000264	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RBX1—Crohn's disease	5.5e-05	0.000263	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RBX1—Crohn's disease	5.47e-05	0.000262	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GCKR—Crohn's disease	5.46e-05	0.000262	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RBX1—Crohn's disease	5.45e-05	0.000261	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	5.41e-05	0.000259	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RBX1—Crohn's disease	5.4e-05	0.000259	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	5.39e-05	0.000258	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	5.38e-05	0.000258	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	5.38e-05	0.000258	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	5.36e-05	0.000257	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	5.36e-05	0.000257	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	5.35e-05	0.000256	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GPX4—Crohn's disease	5.33e-05	0.000255	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	5.33e-05	0.000255	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	5.31e-05	0.000254	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	5.31e-05	0.000254	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GPX4—Crohn's disease	5.28e-05	0.000253	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	5.26e-05	0.000252	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	5.16e-05	0.000247	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GCKR—Crohn's disease	5.15e-05	0.000246	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	5.13e-05	0.000246	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GCKR—Crohn's disease	5.1e-05	0.000244	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	5.09e-05	0.000244	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—STAT3—Crohn's disease	5.06e-05	0.000243	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	4.89e-05	0.000234	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	4.87e-05	0.000233	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	4.82e-05	0.000231	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	4.8e-05	0.00023	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	4.78e-05	0.000229	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	4.74e-05	0.000227	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	4.71e-05	0.000226	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	4.69e-05	0.000224	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	4.68e-05	0.000224	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	4.65e-05	0.000223	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	4.64e-05	0.000222	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	4.59e-05	0.00022	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL3—Crohn's disease	4.56e-05	0.000218	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL3—Crohn's disease	4.54e-05	0.000217	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL3—Crohn's disease	4.52e-05	0.000217	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	4.51e-05	0.000216	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.48e-05	0.000215	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL3—Crohn's disease	4.48e-05	0.000214	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	4.41e-05	0.000211	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	4.39e-05	0.00021	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	4.37e-05	0.000209	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	4.33e-05	0.000207	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	4e-05	0.000192	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	4e-05	0.000191	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	3.98e-05	0.000191	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	3.97e-05	0.00019	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	3.97e-05	0.00019	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	3.96e-05	0.00019	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	3.93e-05	0.000188	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	3.92e-05	0.000188	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.92e-05	0.000188	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	3.81e-05	0.000183	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	3.79e-05	0.000182	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	3.78e-05	0.000181	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	3.74e-05	0.000179	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.71e-05	0.000178	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.65e-05	0.000175	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.65e-05	0.000175	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	3.63e-05	0.000174	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	3.63e-05	0.000174	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	3.62e-05	0.000173	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	3.62e-05	0.000173	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	3.6e-05	0.000173	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	3.59e-05	0.000172	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	3.57e-05	0.000171	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL6—Crohn's disease	3.54e-05	0.000169	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	3.45e-05	0.000165	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	3.43e-05	0.000164	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	3.42e-05	0.000164	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	3.39e-05	0.000162	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TYK2—Crohn's disease	3.32e-05	0.000159	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	3.32e-05	0.000159	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	3.3e-05	0.000158	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	3.29e-05	0.000158	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	3.26e-05	0.000156	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	3.19e-05	0.000153	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.19e-05	0.000153	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TYK2—Crohn's disease	3.18e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	3.18e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—JAK2—Crohn's disease	3.17e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	3.17e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	3.14e-05	0.00015	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—JAK2—Crohn's disease	3.03e-05	0.000145	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	2.89e-05	0.000138	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	2.77e-05	0.000133	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—Crohn's disease	2.75e-05	0.000132	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—Crohn's disease	2.74e-05	0.000131	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—Crohn's disease	2.63e-05	0.000126	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—Crohn's disease	2.4e-05	0.000115	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—Crohn's disease	2.36e-05	0.000113	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—STAT3—Crohn's disease	2.32e-05	0.000111	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	2.25e-05	0.000108	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	2.24e-05	0.000107	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TYK2—Crohn's disease	2.23e-05	0.000107	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—STAT3—Crohn's disease	2.23e-05	0.000107	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	2.21e-05	0.000106	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.15e-05	0.000103	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	2.14e-05	0.000102	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—JAK2—Crohn's disease	2.13e-05	0.000102	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	2.11e-05	0.000101	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—Crohn's disease	2.06e-05	9.87e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—Crohn's disease	1.99e-05	9.55e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	1.96e-05	9.39e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	1.95e-05	9.34e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	1.94e-05	9.31e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	1.92e-05	9.22e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	1.86e-05	8.93e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	1.85e-05	8.88e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—Crohn's disease	1.85e-05	8.85e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	1.83e-05	8.76e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.75e-05	8.36e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—Crohn's disease	1.74e-05	8.32e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—Crohn's disease	1.64e-05	7.84e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—Crohn's disease	1.62e-05	7.78e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—Crohn's disease	1.62e-05	7.78e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.58e-05	7.55e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	1.57e-05	7.51e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—STAT3—Crohn's disease	1.56e-05	7.48e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—Crohn's disease	1.56e-05	7.45e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	1.55e-05	7.41e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—Crohn's disease	1.52e-05	7.28e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.43e-05	6.86e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.42e-05	6.8e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.1e-05	5.27e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—Crohn's disease	1.09e-05	5.24e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—Crohn's disease	1.09e-05	5.23e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—Crohn's disease	1.08e-05	5.18e-05	CbGpPWpGaD
